SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Conditions: Lupus Nephritis; Chronic Kidney Diseases Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Standard maintenance therapy Sponsors: The University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
A Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus; Lupus Nephritis Interventions: Biological: IMPT-514; Biological: IMPT-514; Biological: IMPT-514 Sponsors: ImmPACT Bio Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus Interventions: Other: lipid profile Sponsors: Assiut University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
Conditions: SLE (Systemic Lupus) Interventions: Other: CAR T-cell therapy Sponsors: Chulalongkorn University; King Chulalongkorn Memorial Hospital; Health Systems Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus (SLE) Interventions: Drug: SG301 SC Injection Sponsors: Hangzhou Sumgen Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
Conditions: Telitacicept; Systemic Lupus Erythematosus; Therapy Sponsors: Yanfeng Hou Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Conditions: Systemic Lupus Erythematosus Interventions: Drug: Placebo; Drug: Ianalumab Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus; Lupus Nephritis Interventions: Biological: CABA-201 Sponsors: Cabaletta Bio Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
AntiDFS70 Lupus Nephritis
Conditions: Systemic Lupus Erythematosus Interventions: Diagnostic Test: anti dfs70 antibodies Sponsors: Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Assessment of Safety and Efficacy of SGLT2is Among LN Patients
Conditions: Lupus Nephritis Interventions: Drug: Dapagliflozin 10mg Tab orally once daily Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Clinical Study of CD19 Universal CAR- γδT Cells in Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus Interventions: Biological: CD19 Universal CAR- γδ T Cells Sponsors: Wuhan Union Hospital, China; Guangzhou Bio-gene Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
A Clinical Study of CD19 CAR-T in Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus Interventions: Biological: CD19 CAR-T cell infusion Sponsors: Wuhan Union Hospital, China; Guangzhou Bio-gene Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Pulmonary Disease Among Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic; Pulmonary Disease Interventions: Other: Multidisciplinary discussion Sponsors: Odense University Hospital; Karolinska University Hospital; Hospital of South West Jutland; Vejle Hospital; Sonderborg Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
The Living With a Long-Term Condition Study
Conditions: Asthma; Atrial Fibrillation; Cancer; Cerebrovascular Disorders; Stroke; CKD; Copd; Fibromyalgia; Pain; Heart Diseases; Heart Disease Chronic; Dementia; Diabetes; Epilepsy; Heart Failure; High Blood Pressure; Hypertension; Hiv; AIDS; IBD; IBS; Liver Diseases; Long COVID; Lupus Erythematosus; Multiple Sclerosis; Obesity; Osteoarthritis; Arthritis; Rheumatoid Arthritis; Osteoporosis; Parkinson Disease; Sickle Cell Disease; Hepatitis; Endometriosis; PCOS; Neurological Disorder; POTS - Postural Orthostatic Tachycardia Syndrome; MND (Motor Neurone DIsease); Cystic Fibrosis; Migraine; Spondylitis; Celiac Disease; Hidr...
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Periodontal Status in Patients With Chronic Skin Diseases
Conditions: Periodontal Diseases; Psoriasis; Atopic Dermatitis; Autoimmune Bullous Dermatosis; Systemic Lupus Erythematosus Interventions: Diagnostic Test: oral health status Sponsors: University of Medicine and Pharmacy at Ho Chi Minh City Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
